Jessica A. Lasky Su, Sc.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Genetic Linkage | 8 | 2008 | 2421 | 0.260 |
Why?
|
Metabolome | 1 | 2021 | 895 | 0.240 |
Why?
|
Metabolomics | 1 | 2021 | 1484 | 0.210 |
Why?
|
Fetal Proteins | 1 | 2012 | 94 | 0.100 |
Why?
|
Genetic Predisposition to Disease | 9 | 2012 | 17446 | 0.090 |
Why?
|
Linkage Disequilibrium | 2 | 2005 | 1997 | 0.090 |
Why?
|
T-Box Domain Proteins | 1 | 2012 | 471 | 0.090 |
Why?
|
Schizophrenia | 5 | 2006 | 6882 | 0.080 |
Why?
|
Schizophrenic Language | 1 | 2006 | 69 | 0.070 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2006 | 287 | 0.070 |
Why?
|
Heroin Dependence | 1 | 2006 | 175 | 0.070 |
Why?
|
Interleukin-13 | 1 | 2007 | 389 | 0.060 |
Why?
|
Language Disorders | 1 | 2006 | 141 | 0.060 |
Why?
|
Pedigree | 4 | 2005 | 4644 | 0.060 |
Why?
|
Genome, Human | 3 | 2006 | 4420 | 0.060 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2004 | 299 | 0.060 |
Why?
|
Adrenal Cortex Hormones | 1 | 2012 | 1855 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2012 | 15519 | 0.050 |
Why?
|
Eosinophilia | 1 | 2007 | 541 | 0.050 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2004 | 373 | 0.050 |
Why?
|
Quantitative Trait, Heritable | 1 | 2005 | 544 | 0.050 |
Why?
|
Enzymes | 1 | 2004 | 266 | 0.050 |
Why?
|
Asthma | 3 | 2012 | 6011 | 0.050 |
Why?
|
Receptors, Immunologic | 1 | 2008 | 1423 | 0.050 |
Why?
|
Chromosomes, Human | 1 | 2004 | 457 | 0.050 |
Why?
|
Immunoglobulin E | 1 | 2007 | 1463 | 0.050 |
Why?
|
Chromosome Mapping | 3 | 2006 | 4740 | 0.050 |
Why?
|
Molecular Targeted Therapy | 1 | 2012 | 2727 | 0.050 |
Why?
|
Receptors, Nicotinic | 1 | 2004 | 497 | 0.050 |
Why?
|
Genetic Heterogeneity | 1 | 2004 | 733 | 0.050 |
Why?
|
Glycolysis | 1 | 2004 | 827 | 0.040 |
Why?
|
Databases, Genetic | 1 | 2005 | 1783 | 0.040 |
Why?
|
Point Mutation | 1 | 2004 | 1623 | 0.040 |
Why?
|
Cooperative Behavior | 1 | 2005 | 1504 | 0.040 |
Why?
|
Family | 2 | 2005 | 3147 | 0.040 |
Why?
|
Bipolar Disorder | 2 | 2004 | 5027 | 0.040 |
Why?
|
Genetic Testing | 2 | 2008 | 3444 | 0.040 |
Why?
|
Genome | 1 | 2004 | 1808 | 0.030 |
Why?
|
Chromosomes, Human, Pair 4 | 2 | 2006 | 374 | 0.030 |
Why?
|
Alcoholism | 1 | 2005 | 1906 | 0.030 |
Why?
|
Nerve Tissue Proteins | 1 | 2008 | 4462 | 0.030 |
Why?
|
Lod Score | 2 | 2006 | 614 | 0.030 |
Why?
|
Genotype | 5 | 2012 | 12951 | 0.030 |
Why?
|
Neuropsychological Tests | 1 | 2006 | 6993 | 0.030 |
Why?
|
Genome-Wide Association Study | 2 | 2012 | 12261 | 0.020 |
Why?
|
Sex Distribution | 2 | 2006 | 2297 | 0.020 |
Why?
|
China | 2 | 2006 | 2248 | 0.020 |
Why?
|
Body Mass Index | 1 | 2008 | 12720 | 0.020 |
Why?
|
Gene Frequency | 2 | 2008 | 3588 | 0.020 |
Why?
|
Genetic Markers | 2 | 2006 | 2634 | 0.020 |
Why?
|
Pharmacogenetics | 1 | 2012 | 675 | 0.020 |
Why?
|
Respiratory Function Tests | 1 | 2012 | 1616 | 0.020 |
Why?
|
Costa Rica | 1 | 2007 | 177 | 0.020 |
Why?
|
Alleles | 2 | 2012 | 6933 | 0.020 |
Why?
|
Smoking | 1 | 2004 | 8987 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2006 | 6038 | 0.020 |
Why?
|
Linguistics | 1 | 2006 | 97 | 0.020 |
Why?
|
Language Tests | 1 | 2006 | 200 | 0.020 |
Why?
|
Obesity | 1 | 2008 | 12745 | 0.020 |
Why?
|
Taiwan | 1 | 2006 | 496 | 0.020 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2006 | 437 | 0.020 |
Why?
|
Phosphofructokinase-1 | 1 | 2004 | 51 | 0.020 |
Why?
|
Phonetics | 1 | 2006 | 206 | 0.020 |
Why?
|
Phosphofructokinase-2 | 1 | 2004 | 32 | 0.020 |
Why?
|
Hexokinase | 1 | 2004 | 125 | 0.010 |
Why?
|
Phenotype | 3 | 2007 | 16365 | 0.010 |
Why?
|
Phenylalanine Hydroxylase | 1 | 2002 | 30 | 0.010 |
Why?
|
Nuclear Family | 1 | 2004 | 318 | 0.010 |
Why?
|
Male | 11 | 2012 | 350118 | 0.010 |
Why?
|
Chromosomes, Human, Pair 20 | 1 | 2002 | 133 | 0.010 |
Why?
|
Pyruvate Kinase | 1 | 2004 | 189 | 0.010 |
Why?
|
Semantics | 1 | 2006 | 584 | 0.010 |
Why?
|
Female | 11 | 2012 | 380194 | 0.010 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2002 | 380 | 0.010 |
Why?
|
Principal Component Analysis | 1 | 2004 | 940 | 0.010 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2002 | 462 | 0.010 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2002 | 535 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2006 | 2886 | 0.010 |
Why?
|
Humans | 14 | 2012 | 744343 | 0.010 |
Why?
|
Interleukin-10 | 1 | 2005 | 1200 | 0.010 |
Why?
|
Brain | 1 | 2006 | 26385 | 0.010 |
Why?
|
Functional Laterality | 1 | 2006 | 2290 | 0.010 |
Why?
|
Haplotypes | 1 | 2005 | 2779 | 0.010 |
Why?
|
Adult | 6 | 2012 | 214055 | 0.010 |
Why?
|
Child, Preschool | 2 | 2012 | 41006 | 0.010 |
Why?
|
Age of Onset | 1 | 2004 | 3271 | 0.010 |
Why?
|
Child | 3 | 2012 | 77709 | 0.010 |
Why?
|
Adolescent | 3 | 2012 | 85781 | 0.010 |
Why?
|
Middle Aged | 5 | 2012 | 213383 | 0.010 |
Why?
|
Linear Models | 1 | 2006 | 5952 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2006 | 2708 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2012 | 15540 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2004 | 4328 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2006 | 12245 | 0.010 |
Why?
|
Sex Factors | 1 | 2006 | 10397 | 0.010 |
Why?
|
Computer Simulation | 1 | 2005 | 6196 | 0.010 |
Why?
|
Prognosis | 1 | 2012 | 29063 | 0.010 |
Why?
|
Age Factors | 1 | 2008 | 18370 | 0.010 |
Why?
|
Gene Expression | 1 | 2004 | 7799 | 0.010 |
Why?
|
Software | 1 | 2005 | 4443 | 0.010 |
Why?
|
Risk Assessment | 1 | 2012 | 23338 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2008 | 25043 | 0.000 |
Why?
|
Infant | 1 | 2008 | 35136 | 0.000 |
Why?
|
Young Adult | 1 | 2012 | 56430 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2012 | 63114 | 0.000 |
Why?
|
Cohort Studies | 1 | 2008 | 40561 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2008 | 57776 | 0.000 |
Why?
|
Risk Factors | 1 | 2004 | 72290 | 0.000 |
Why?
|
Aged | 1 | 2008 | 163280 | 0.000 |
Why?
|